Here’s what you should know:
1. The capsule has lose-dose X-ray technology and a wireless tracking system. After ingestion, the capsule generates structural information on the colon’s lumen.
2. Physicians can use the information to create 2-D and 3-D maps of the colon, allowing for the identification of pre-cancerous polyps and abnormalities.
3. The company designed C-Scan as an alternative to colonoscopy preparation solutions, which are commonly cited as the reason why patients put off colonoscopies.
4. Check-Cap CEO Bill Densel said, “Achieving CE Mark approval is a significant accomplishment and an important milestone for our Company. This is a key validation of C-Scan and its potential as a convenient and comfortable option for identifying polyps in the colon.”
5. Check-Cap is in the midst of launching an European post-approval study and a U.S. pilot study. It’s anticipated both trials will launch in 2018.
More articles on gastroenterology:
GI leader to know: Dr. Kent Katz of Wyoming Medical Center
Drs. Arnold Levy, Michael Sue & more: 4 GI physicians making headlines
Modernizing Medicine taps Dr. Arnold Levy for advisor role — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.